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Abstract
Background: Previous studies have demonstrated that adverse events occur during chiropractic treatment.
However, because of these studies design we do not know the frequency and extent of these events when
compared to sham treatment. The principal aims of this study are to establish the frequency and severity of
adverse effects from short term usual chiropractic treatment of the spine when compared to a sham treatment
group. The secondary aim of this study is to establish the efficacy of usual short term chiropractic care for spinal
pain when compared to a sham intervention.
Methods: One hundred and eighty participants will be randomly allocated to either usual chiropractic care or a
sham intervention group. To be considered for inclusion the participants must have experienced non-specific
spinal pain for at least one week. The study will be conducted at the clinics of registered chiropractors in Western
Australia. Participants in each group will receive two treatments at intervals no less than one week. For the usual
chiropractic care group, the selection of therapeutic techniques will be left to the chiropractors’ discretion. For the
sham intervention group, de-tuned ultrasound and de-tuned activator treatment will be applied by the
chiropractors to the regions where spinal pain is experienced. Adverse events will be assessed two days after each
appointment using a questionnaire developed for this study. The efficacy of short term chiropractic care for spinal
pain will be examined at two week follow-up by assessing pain, physical function, minimum acceptable outcome,
and satisfaction with care, with the use of the following outcome measures: Numerical Rating Scale, Functional
Rating Index, Neck Disability Index, Minimum Acceptable Outcome Questionnaire, Oswestry Disability Index, and a
global measure of treatment satisfaction. The statistician, outcome assessor, and participants will be blinded to
treatment allocation.
Trial registration: Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12611000542998
Background
The success of any therapy is often based on the ques-
tions “Is it safe? Is it effective?”. For chiropractic therapy
there has been some research to ascertain effectiveness
[1] and also for spinal manipulation [2] but there has
been very little to document its safety. The safety profile
of any therapy is a cornerstone of modern practice as it
provides protection for the public and informs the con-
sumer consent process. Trials of chiropractic therapy
have shown mixed results which, together with its
current use for multiple indications, make research into
aspects of its safety important.
There are several published reports about the safety of
chiropractic treatment. A single arm study conducted by
Senstad et al in 1996 [3] reviewed the type, frequency,
and characteristics of unpleasant side effects after spinal
manipulation. About half of the patients reported at
least one adverse event some time during the course of
a maximum of six treatments. Of these, the most com-
mon adverse events were local discomfort (53%), head-
ache (12%), tiredness (11%),o rr a d i a t i n gd i s c o m f o r t
(10%). Adverse events were mild or moderate in 85% of
patients. Limitations of this study included that the chir-
opractors gathered their own data; responders could not
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not be obtained from patients who attended one treat-
ment only. It is possible that some opted out because of
unpleasant reactions, potentially making the results an
underestimate.
Hurwitz et al compared the rate of adverse events
between two randomly allocated groups of neck patients
who received either manipulation or mobilisation from
chiropractors [4]. About a third of all participants
reported at least one adverse event. The most common
adverse events were increased pain (27%), headache
(15%), tiredness (12%), radiating pain (6%), and dizziness
(4%). Participants who received manipulation were more
likely to experience an adverse event than participants
who received mobilisation.
A prospective survey of chiropractors in the United
Kingdom examined adverse events following manipula-
tion of the neck [5]. No serious adverse events were
reported. Of the adverse events reported, the most nota-
ble were increased neck pain (7%) and increased
shoulder/arm pain (4%), muscle stiffness and headache
(4%). A potential limitationo ft h i ss t u d yw a st h a td a t a
were collected by the chiropractors administering the
intervention, which may have led to an underestimation
of adverse events.
The fourth study was a prospective study of patients
who received chiropractic care for neck pain [6]. Just
over half of the participants experienced at least one
adverse event following any of the three treatments, and
13% of the adverse events were severe in intensity.
About 75% of all reported adverse events were muscu-
loskeletal or pain related. Other less common adverse
events included tiredness, dizziness, nausea, or ringing
in the ears.
The main limitation associated with these four studies
above [3-6] was that three of the studies were uncon-
trolled. These uncontrolled studies may have overesti-
mated the frequency of adverse events because the
reported events may be associated with either natural
history [6] or a placebo response [7].
Another limitation concerns the involvement of chiro-
practors in collecting information about adverse events
directly from the participants in two of the studies [3,5].
The involvement of chiropractors may have led to an
underestimation of adverse events as the patients may
have been reluctant to disclose the events they
experienced.
Given the limitations associated with previous studies
of adverse events during chiropractic care [3-6], it is evi-
dent that controlled studies are warranted to develop a
better understanding of the rate of adverse events in
chiropractic care. This proposition reflects the findings
of a recent systematic review [8] that concluded there
were no robust data concerning rate of adverse events
after chiropractic treatment and recommended urgent
investigations to provide definitive conclusions as to its
safety profile.
In summary, the literature reveals that adverse events
do happen from chiropractic therapies. However, pre-
vious studies have limitations and therefore we do not
know the frequency and extent of these events particu-
larly when compared to sham treatment.
Aims
1. To establish the frequency and severity of adverse
events from usual short term chiropractic treatment of
the spine when compared to a sham treatment.
2. To establish the efficacy of usual short term chiro-
practic care for spinal pain when compared to a sham
intervention.
Materials and methods
This study will be a randomised, placebo-controlled trial
comparing usual short term chiropractic care and a
sham intervention of no known benefit for participants
with non-specific spinal pain of more than one week in
duration. The inclusion of a placebo group will allow for
a comparison of adverse events between active chiro-
practic care and those that are a manifestation of either
“sham” treatment or natural history. Participants will be
randomly allocated to receive usual chiropractic care or
a sham intervention consisting of non-functional thera-
peutic ultrasound and a de-tuned Activator
® instrument
[9]. The reporting of the results of this trial will accord
with both the extended CONSORT statement for Ran-
domized Trials of Nonpharmacologic Treatment [10]
and the CONSORT extension for Better Reporting of
Harms in Randomized Trials [11].
Study Sample and Participant Enrolment
Participants will be recruited in Perth, Western Australia
by the use of newspaper advertisements. Any person
who responds to the advertisement by phone will be
considered a potential candidate and will receive
through the mail the following documents:
￿ an information letter;
￿ a pain diagram to assess symptom location and
distribution;
￿ the Numerical Rating Scale (NRS) [12] on which
the patients will score their current overall level of
spinal pain;
￿ Functional Rating Index (FRI) [13];
￿ a questionnaire enquiring about the minimum
amount of change in pain levels that potential parti-
cipants would consider to be an acceptable outcome
[14];
￿ a medical history checklist.
Walker et al. Trials 2011, 12:235
http://www.trialsjournal.com/content/12/1/235
Page 2 of 8These documents will be returned in a reply paid
envelope and the information will be used to determine
eligibility. To be considered for inclusion, potential par-
ticipants must be adults (18 years or older), literate in
English, and have had spinal pain (neck pain, mid-back
pain, or low back pain) for more than 1 week. In addi-
tion, potential participants must score at least 3 on the
NRS and 12 on the FRI as this allows measurement of a
minimal clinically important difference in the improve-
ment direction [15].
Potential participants will be excluded if they:
￿ have been previously unable to tolerate common
chiropractic treatments, for example: manipulation;
mobilisation; Activator
®; flexion distraction therapy;
traction; soft tissue massage; trigger point therapy;
sacro-occipital technique; ultrasound; interferential
therapy; and Transcutaneous Electrical Nerve Stimu-
lation (TENS).
￿ have any of the following conditions: spinal pain
related to cancer or infection; clinically important
fracture of the spine; spondyloarthropathy; known
osteoporosis; progressive upper or lower limb weak-
ness; symptoms of cauda equina syndrome or other
important neurological condition; recent disc hernia-
tion; cardiovascular disease likely to be a contraindi-
cation to spinal manipulation; uncontrolled
hypertension; cognitive impairment; blood coagula-
tion disorder; spinal surgery in the last year; previous
history of stroke or transient ischaemic attacks; have
a pacemaker or other electrical device implanted; are
currently pregnant;
￿ have a current compensation claim;
￿ have a substance abuse problem;
￿ cannot commit to study protocol.
Potential participants who satisfy the inclusion criteria
will be sent a more detailed information letter. Two days
later, they will be contacted by phone to determine if
they are interested in participating, and if so an appoint-
ment will be made to attend Murdoch University.
Chiropractor Participants
The study interventions will be administered at the
clinics of registered chiropractors in Perth, Western
Australia. Recruitment of about 12 chiropractors will be
by way of open advertisement to the profession using
contact details in the public domain or from the online
Register of Chiropractors. To be eligible, chiropractors
must have had at least two years of clinical experience
and regularly use spinal manipulation in the mix of
their therapy modalities. Chiropractors who administer
t h es h a mi n t e r v e n t i o nm u s th a v eb o t hu l t r a s o u n da n d
Activator
® instruments available.
Treatment allocation
When participants visit Murdoch University and after
baseline measures and consent have been obtained, one
of the research staff, excluding the research assistant
(RA) and statistician, will randomly allocate the partici-
pants to one of the two groups using a 1:1 allocation. A
statistician will generate a permuted block randomiza-
tion sequence allocating persons to either chiropractic
care or the sham group. The group assignment will be
written on small cards and placed in opaque envelopes.
For ethical reasons, participants in the sham group
will be offered two treatments of usual chiropractic care
two weeks after receiving the last sham treatment and
following receipt of their final outcome measures by the
RA. Any participant who discontinues treatment will be
followed-up to determine the reason for discontinuation.
Pilot Study
A pilot study, using the first five participants recruited,
will be undertaken to evaluate process and resource
issues. In particular, we will examine whether the parti-
cipants were able to complete the questionnaires in full
without difficulty and the length of time required. All
research team members involved with baseline assess-
ments and randomisation will meet after the first five
participants have been randomised to reach a consensus
decision on the feasibility of administering the question-
naires. In the absence of explicit recommendations
about the required sample size to examine feasibility
issues, we determined that five participants would be
sufficient [16].
Intervention/treatment
Chiropractors will be asked to deliver one of the two
study interventions. The study interventions are as
follows:
1. Short term usual chiropractic care: a series of two
chiropractic treatments to the spine as deemed suitable
by a registered chiropractor. Treatments include one or
more of the following: spinal manipulation, mobilisation,
drop piece, traction, electro- therapies, ultrasound, Acti-
vator
®, soft tissue techniques and other manual techni-
ques offered by the chiropractor. This treatment
approach replicates a common pragmatic approach in
the field [1].
2. Sham Group: participants will receive two sessions
of de-tuned ultrasound and de-tuned Activator
® treat-
ment by a chiropractor to the regions where spinal pain
is experienced. There is no known treatment benefit
from the de-tuned ultrasound machine and it has been
established in previous trials as a credible treatment
option by patients [17,18]. Chiropractors will be directed
to wind the Activator
® head force to minimum and then
administer the force through a wooden tongue
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areas of concern. The dimensions of the depressor are
19 mm wide and 150 mm long, although on average
only 600 mm of the length will be in contact with the
skin. This means a surface area of 1140 mm
2.W em e a -
sured the force this will provide to the skin using a
force transducer. The mean of 5 measured attempts was
a very low 3.7 kPa. To increase the perceived “hands
on” credibility, the chiropractor will be trained to gently
place one hand on an area adjacent to the participant’s
spine while delivering the ultrasound and Activator
®
therapies. The four chiropractors recruited to deliver the
sham treatment will be asked to administer the sham
interventions as they normally use Activator
® tools and
ultrasound and with the same enthusiasm they would
use for all other therapies.
Withdrawing Participants from this Study
A stopping rule was defined for withdrawing partici-
pants from this study in accordance with recommenda-
tions in the CONSORT extension for Better Reporting
of Harms [11]. If a participant reports to their chiro-
practor or research staff a severe adverse event they will
be withdrawn from the study and referred to their local
doctor or hospital emergency department depending on
the nature of the event. Each participant will complete
an adverse event questionnaire two days after each chir-
opractic appointment and asked to then return it in a
reply paid envelope. Any adverse event will be classified
as severe if it is thought to be an emergency situation e.
g. stroke or the associated pain intensity is rated above
8/10 on an 11 point NRS, which accords with the defini-
tion for a serious adverse event by Rubinstein et al [6].
Ethical Clearance
All participants (chiropractors and patients’ with spinal
pain) will provide voluntary written informed consent
with a full understanding of what study participation
entails and the potential risks. Ethics approval has been
obtained from Murdoch University’s Human Research
Ethics Committee (Reference number 2011/109).
Demographic Material and Assessment of Outcomes
1. Chiropractor Demographics and Usual Chiropractic Care
Characteristics
For the participating chiropractors, the following demo-
graphic characteristics will be collected: age, years in
practice, institution from which qualifications were
obtained, and speciality certification or additional quali-
fications. A treatment checklist will be used to collect
information about the types of treatments used in each
usual chiropractic care appointment. Collection of the
demographic and treatment information accords with
the CONSORT Recommendations for the Reporting of
Nonpharmacologic Trials [10]. Information about the
types of treatment used will also be used for later analy-
sis and correlation with adverse events.
2. Baseline Assessment
The following questionnaires will be administered at
baseline: demographic questionnaire; NRS [12]; FRI [13];
Fear-Avoidance Behaviour Questionnaire (FABQ) [19];
SF-36 [20]; STarT Back Musculoskeletal Screening Tool
[21]; and the Pain Catstrophising Scale (PCS) [22]. Also,
the primary area of concern for each participant will be
identified and one of the following questionnaires speci-
f i ct ot h a ta r e aw i l lb ea d m i n i s t e r e d :t h em o d i f i e d
Oswestry Disability Index (ODI) [23]; or Neck Disability
Index (NDI)[24].
Descriptive statistics from the baseline measures
including the SF-36, STarT Back Musculoskeletal
Screening Tool, and demographic questionnaire will be
examined to determine if clinically important differences
are evident between the usual chiropractic group and
sham group at baseline. The SF-36 is a well validated
and extensively used measure of general health status
[25]. The STarT Back Musculoskeletal Screening Tool is
brief validated instrument that has been developed to
identify people with chronic pain who are more likely to
experience persistent symptoms [21]. The demographic
questionnaire enquires about age, sex, race/ethnicity,
education, household income, marital status, employ-
ment status, smoking, and alcohol and legal drug con-
sumption. These items were derived from classifications
used by the Australian Bureau of Statistics [26].
A baseline symptom checklist will be administered to
examine whether the adverse events that participants
reported after each chiropractic treatment were actually
an adverse event or the persistence of a presenting com-
plaint. This will be achieved through comparing data
from the symptom checklist taken at baseline to data
from the adverse event checklist collected after each
chiropractic treatment.
The NRS contains an 11-point scale varying from 0
(no pain) to 10 (worst pain imaginable) [12]. It is a
valid, reliable and responsive measure of pain intensity
[27]. Participants will be asked to use the scale to rate:
their worst level of pain in the last two days; average
pain level in the last two days; best pain level in the last
two days; and current pain.
The FRI contains 10 questions which enquire about
the impact of neck and back pain on physical function.
It was designed to assess conditions where more than
one area of the spine is involved and is valid, reliable
and responsive [13].
The NDI was designed to measure neck-specific dis-
ability. The questionnaire has 10 items concerning pain
and activities of daily living. It has demonstrated validity,
reliability and responsiveness [24].
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sure that has been shown to have high levels of reliabil-
ity, validity and responsiveness in patients with low back
pain [23]. It assesses impact of low back pain on physi-
cal function and activities of daily living.
The FABQ will be used to assess participant’sb e l i e f s
about the relationships between back pain, work, and
physical activity. The FABQ has good test-retest reliabil-
ity [19], and predictive validity for future episodes of
LBP [23] and clinical outcome [15].
Catastrophising will be assessed with the PCS [22].
The PCS assesses different dimensions of negative
thoughts related to pain: rumination, magnification, and
helplessness. It contains 13 items scored on a 5-point
Likert-type scale varying from 0 ("not at all”) to 4 ("all
the time”). The PCS has been shown to be a reliable
and valid measure which predicts postoperative pain
intensity following lumbar spine surgery [28].
3. Assessment of Adverse Event Events
To accord with the CONSORT extension for Better
Reporting of Harms [11], it is necessary to ap r i o r i
define anticipated and unanticipated adverse events and
explicitly state these definitions in reporting the meth-
ods for this study. Anticipated adverse events for this
study are defined as the adverse events listed in the
questionnaire developed for this study and any of the
other adverse events reported in the studies conducted
by Senstad et al. [3], Hurwitz et al. [4], Rubinstein et al.
[6], and Theil et al. [5]. Unanticipated adverse events
will be defined as stroke, fracture, dislocation, or disc
injury.
Information about adverse events will be collected
after each chiropractic appointment. Participants will be
asked to complete the questionnaire two days after each
appointment as adverse events typically manifest within
two days of chiropractic treatment [3,4,6].
The adverse events questionnaire [Additional file 1]
was derived from a checklist used by Cagnie et al. [29];
open-ended questions from Senstad et al. [3] and Hur-
witz et al. [4]; adverse events reported in RCT’s
[4,6,29-32]; and two surveys [5,33]. It consists of items
which enquire about the onset and severity of adverse
events, and items about the impact of adverse events on
activities of daily living. We decided to use a question-
naire which consisted largely of predefined response
options as previous studies have demonstrated that the
use of predefined response options results in more com-
prehensive reporting of adverse events [34].
4. Assessment at Two Week Follow-Up
We will administer at two week follow-up the NRS [12],
FRI [13], and the area specific instruments modified
ODI [23] or NDI [24]. These questionnaires will be used
to establish the short term efficacy of brief chiropractic
care for spinal pain. The FABQ [19] and PCS [22] will
also be administered to examine whether cognitive
aspects related to the experience of pain influence pain
severity, physical function and adverse events.
Also, a global measure of treatment satisfaction [27]
and global measure of perceived change [35] will be
administered at two week follow-up. The global measure
of treatment satisfaction [27] will be used to examine
the association between adverse events and treatment
satisfaction. It will be measured on a five point categori-
cal scale (very dissatisfied = 0; dissatisfied = 1; no pre-
ference = 2; satisfied = 3; very satisfied = 4). The global
measure of perceived change [35] will be used to exam-
ine the association between adverse events and overall
perceived change in the main complaint. It will be mea-
sured on an 11 point continuous scale varying from -5
to +5 (-5 = much worse, 0 = unchanged, +5 much
better).
Blinding will be assessed at two weeks with a ques-
tionnaire [36] that asks the participants if they were in
the real treatment group or the sham treatment group.
The possible responses are: real treatment group; sham
group; or don’t know.
Blinding
Practitioners are unable to be blinded with respect to
the participants’ treatment group allocation. The statisti-
cian and research assistant will remain blind to treat-
ment allocation. We aim to blind participants to the
assigned treatment throughout the trial.
Sample Size
The sample size was based on the number needed to
detect a significant difference in the primary outcome
(adverse event: yes/no) between groups. We make the
assumption that in the usual chiropractic group 45% of
patients will experience an adverse event and that the
rate in the sham group will be 25%. We believe this is a
very conservative estimate given that a) the participants
in the Senstad et al. study [3] had 6 treatments and
there was a rate of 55% adverse events and b) that for
the sham treatment previous studies have shown a mild
adverse event rate of 7% [37] using the same de-tuned
ultrasound method. Therefore, using a 2-sided test and
alpha level of 0.05, recruiting 90 participants in each
group (180 total) will provide 80% power to detect a dif-
ference this large or larger. G*Power 3.1.3 was used to
calculate the sample size [38].
Statistical Methods
Data will be entered and analysed in SPSS Version 17.
Data will be checked for implausibility’sb yu s i n gaf r e -
quency analysis of each variable. In addition, a second
check of half the data entered will be made in detail for
errors. Descriptive statistics will be derived for the parti-
cipants’ and chiropractors’ demographic characteristics,
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taken at baseline for the participants will be compared
to establish whether the groups are similar.
Analysis of Adverse Events
The primary outcome (adverse event; yes/no) will be
compared between groups. The severity and frequency
of adverse events will be reported descriptively. Logistic
regression will be used to examine associations between
adverse events and several factors. Factors which have
been significantly associated with adverse events in pre-
vious studies will be selected for this study. These
factors comprise treatment satisfaction [4], manipula-
tion/mobilisation [4], global improvement [4], GP visit
in last six months [6], duration of neck/back pain [6],
medication use [29], gender [29], and age [29]. The rela-
tive risk [39] will be calculated using a two by two con-
tingency table and 95% confidence intervals. The
number needed to harm [40] will be calculated with
95% confidence intervals to identify the number of indi-
viduals needed to be exposed to a risk factor (chiroprac-
tic treatment) over a specific period to cause harm
(adverse outcome) in one patient that would not
1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mailed Out: brief invitation 
letter; NRS; FRI; MAO 
questionnaire; medical history 
checklist; pain diagram 
Excluded if: NRS <3 FRI<12; meets 
other exclusion criteria 
Potential Participants sent 
detailed information letter and 
invited by phone to Murdoch for 
baseline assessment 
Excluded if not willing to sign consent 
form at visit to Murdoch 
Measures administered at 
baseline: demographic 
questionnaire; SF-36; PCS; FABQ; 
NRI; FRI; ODI or modified ODI or 
NDI 
Randomised (n=180)  n=90 allocated to 
usual chiropractic care 
n=90 allocated to              
placebo intervention 
Outcome assessment 
  adverse event questionnaire administered 
after treatment 1 & 2 
  Measures administered at two weeks  & two 
week follow up: NRS; FRI; ODI or modified ODI 
or NDI; GPC; GTS; blinding index; PCS; FABQ 
Lost to follow up, n= 
Discontinued intervention, n= 
Lost to follow up, n= 
Discontinued intervention, n=  
Analysed, n= 
Excluded from analysis, n= 
Analysed, n= 
Excluded from analysis, n= 
Figure 1 Study Flow.
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using per protocol analysis. In addition, an intention to
treat analysis will be undertaken by using sequential
regression multiple imputation [41].
Analysis of Secondary Outcomes
The efficacy of short term usual chiropractic care will
assessed in two ways. First, for the repeated measures
ANOVA will be used to compare differences between
groups for the pain and physical function measures. Sec-
ond, the minimum acceptable outcome [14], which
involves establishing what participants consider to be a
“minimum acceptable outcome” for which they would
undertake a procedure. The proportion of participants
meeting this target in each group will be reported
descriptively and the groups will be compared by using
a chi-squared test [14].
Blinding to treatment allocation will be assessed by
using the Bang Index (BI) [36] which will allow us to
determine if a significant proportion of participants
guessed that they were in opposite treatment group. A
BI value of < -0.2 indicates that significant proportion
guessed wrongly, BI between 0.2 and -0.2 indicates par-
ticipants guessed randomly, and BI > 0.2 indicates that
the study was unblinded.
Study Flow
A flow chart of the study is seen in Figure 1.
Discussion
To our knowledge, this is the first study to use a sham-
controlled arm to examine the rate of adverse events
during chiropractic care. It also appears to be the first
controlled study to investigate how often adverse events
occur during chiropractic care for spinal pain, as the
only other controlled chiropractic study examined
adverse events for chiropractic treatment of neck pain.
The findings of this study will build on the limited num-
ber of previous studies conducted to examine adverse
events during chiropractic care and contribute towards
a more robust understanding of the safety profile of
chiropractic care. In particular, the inclusion of a sham
a r mw i l le n a b l eu st ob e t t e rd i s c e r nt h er a t eo fa c t u a l
a d v e r s ee v e n t sb yc o m p a r i n gthe frequency of adverse
events that occurred in the usual chiropractic care
group to those in the sham controlled group. This study
will also provide additional evidence about the efficacy
of short term usual chiropractic care for spinal pain.
There are three main limitations associated with the
conduct of this study. First, we will only be able to pro-
vide two treatment sessions to each participant due to
funding constraints. Consequently, in all likelihood our
study will only capture the most common adverse
events of chiropractic care. Second, the internal validity
of this trial would have been enhanced by having the
same chiropractors provide both interventions. However,
we decided to use a different group of chiropractors to
provide each intervention as we anticipated difficulty in
recruiting sufficient chiropractors with access to both
ultrasound and Activator
® instruments, both of which
are required to administer the sham intervention. Third,
the extent to which we can accurately determine the
relative risk of usual chiropractic care depends on how
well we are able to maintain blinding to treatment allo-
cation. We acknowledge that it may be difficult to blind
the participants with spinal pain to the assigned treat-
ment throughout the trial and accordingly will examine
blinding through administering a questionnaire. How-
ever, our findings about the success of blinding should
be viewed cautiously as the questionnaire we will use to
assess blinding has not been formally validated.
Additional material
Additional File 1: Adverse Events in Chiropractic Care
Questionnaire. Survey instrument developed for this study to gather
information about adverse events.
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